Biochemical Pharmacology · 2007 · 58 citations · 28 references
MedicineMolecular GeneticsOncologyChemotherapyDna RepairMolecular OncologyApoptosis ResistanceColorectal CancerDna Damage-induced ApoptosisMalignant NeoplasmsTumor BiologyTumor Suppressor GenesOxaliplatin-based TherapyP53 AbnormalityP53 InactivationP53 MutationP53 Pathway InactivationSensitivityTumor Suppressor P53
28
Bert Vogelstein, David P. Lane, Arnold J. Levine · Nature · 2000 · 6.6K citations
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
Thierry André, C. Boni, Lamia Mounedji-Boudiaf et al. · New England Journal of Medicine · 2004 · 3.7K citations · Full text
Sylvie Giacchetti, B Perpoint, Rachid Zidani et al. · Journal of Clinical Oncology · 2000 · 1.4K citations
Medicine, Oncology, Pharmacology +14
Disruption of p53 in human cancer cells alters the responses to therapeutic agents
Fred Bunz, Paul M. Hwang, Chris Torrance et al. · Journal of Clinical Investigation · 1999 · 1.1K citations · Full text
Medicine, Cancer Biology, Oncology +17
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
Elsa R. Flores, Kenneth Y. Tsai, Denise Crowley et al. · Nature · 2002 · 804 citations